Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The kallikrein-kinin system in diabetic retinopathy.

Bhat M, Pouliot M, Couture R, Vaucher E.

Prog Drug Res. 2014;69:111-43. Review.

PMID:
25130041
2.

Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.

Pruneau D, Bélichard P, Sahel JA, Combal JP.

Curr Opin Investig Drugs. 2010 May;11(5):507-14. Review.

PMID:
20419596
3.

The kallikrein/kinin system in ocular function.

Webb JG.

J Ocul Pharmacol Ther. 2011 Dec;27(6):539-43. doi: 10.1089/jop.2011.0187. Epub 2011 Dec 2. Review.

PMID:
22136090
4.

Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.

Wilkinson-Berka JL, Fletcher EL.

Curr Pharm Des. 2004;10(27):3313-30. Review.

PMID:
15544518
5.

The Role of Plasma Kallikrein-Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches.

Abdulaal M, Haddad NM, Sun JK, Silva PS.

Semin Ophthalmol. 2016;31(1-2):19-24. doi: 10.3109/08820538.2015.1114829. Review.

PMID:
26959125
6.

Kallikrein-kinin system mediated inflammation in Alzheimer's disease in vivo.

Viel TA, Buck HS.

Curr Alzheimer Res. 2011 Feb;8(1):59-66. Review.

PMID:
21143155
7.

Plasma kallikrein-kinin system and diabetic retinopathy.

Liu J, Feener EP.

Biol Chem. 2013 Mar;394(3):319-28. doi: 10.1515/hsz-2012-0316. Review.

8.

Genetic manipulation and genetic variation of the kallikrein-kinin system: impact on cardiovascular and renal diseases.

Girolami JP, Blaes N, Bouby N, Alhenc-Gelas F.

Prog Drug Res. 2014;69:145-96. Review.

PMID:
25130042
9.

Alternative pathways in the development of diabetic retinopathy: the renin-angiotensin and kallikrein-kinin systems.

Phipps JA, Jobling AI, Greferath U, Fletcher EL, Vessey KA.

Clin Exp Optom. 2012 May;95(3):282-9. doi: 10.1111/j.1444-0938.2012.00747.x. Review.

10.

The kallikrein-kinin pathways in hypertension and diabetes.

Sharma JN, Narayanan P.

Prog Drug Res. 2014;69:15-36. Review.

PMID:
25130038
11.

Development of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling.

Tschöpe C, Westermann D.

Biol Chem. 2008 Jun;389(6):707-11. doi: 10.1515/BC.2008.082. Review.

PMID:
18627288
12.

Plasma kallikrein and diabetic macular edema.

Feener EP.

Curr Diab Rep. 2010 Aug;10(4):270-5. doi: 10.1007/s11892-010-0127-1.

PMID:
20535647
13.

Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.

Vora JP, Oyama TT, Thompson MM, Anderson S.

Diabetes. 1997 Jan;46(1):107-12.

PMID:
8971089
14.

Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.

Kita T, Clermont AC, Murugesan N, Zhou Q, Fujisawa K, Ishibashi T, Aiello LP, Feener EP.

Diabetes. 2015 Oct;64(10):3588-99. doi: 10.2337/db15-0317. Epub 2015 May 15.

15.

Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.

Tschöpe C, Reinecke A, Seidl U, Yu M, Gavriluk V, Riester U, Gohlke P, Graf K, Bader M, Hilgenfeldt U, Pesquero JB, Ritz E, Unger T.

Am J Physiol. 1999 Dec;277(6 Pt 2):H2333-40.

16.

[Kallikrein-kinin system as a target for diabetic retinopathy treatment].

Iarovaia GA, Neshkova EA, Blokhina TB, Kochergin SA, Vorob'eva IV, Gigineishvili DN.

Vestn Oftalmol. 2012 Jul-Aug;128(4):78-81. Review. Russian.

PMID:
22994115
17.

Expression and cellular localization of the kallikrein-kinin system in human ocular tissues.

Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J.

Exp Eye Res. 1996 Jul;63(1):19-26.

PMID:
8983960
18.

The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney.

Phipps JA, Feener EP.

Kidney Int. 2008 May;73(10):1114-9. doi: 10.1038/ki.2008.9. Epub 2008 Feb 13. Review.

19.

Kallikrein and kinin receptor genes.

Mahabeer R, Bhoola KD.

Pharmacol Ther. 2000 Oct;88(1):77-89. Review.

PMID:
11033385
20.

Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases.

Schremmer-Danninger E, Naidoo S, Neuhof C, Valeske K, Snyman C, Sander C, Bhoola KD, Neuhof H.

Biol Chem. 2004 Nov;385(11):1069-76.

PMID:
15576327

Supplemental Content

Support Center